Soligenix, Inc. maintains its Nasdaq listing for market access and is actively seeking non-dilutive funding for its Ebola vaccine program.
2 reports, 1 independent
Updated Aug 7
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 2
- Developments
- 1
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Soligenix, Inc. maintains its Nasdaq listing for market access and is actively seeking non-dilutive funding for its Ebola vaccine program.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
-
Coalition for Epidemic Preparedness Innovations
Public-private organization for vaccine development
Nothing else this week.
Related events
- Rocket is utilizing Nasdaq for investor evaluation and the FDA reviewed Phase 2 efficacy data for its product RP-A501.
- Generate Biomedicines Inc listed its shares on the Nasdaq stock exchange on August 25, 2026.
- Alvotech utilized Nasdaq for its public stock listing and is currently undergoing comprehensive review by the FDA for biosimilar applications.
- Nasdaq hosts listings for small-cap healthcare companies, including Silo Pharma, Inc. and Ovid Therapeutics.
- A market rally was observed in the biotech sector, driven by positive cancer vaccine news, causing Eli Lilly shares to rise.